Jeffrey E. Russel

Array ( [id] => 4131781 [patent_doc_number] => 06034067 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Serine protease inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/125169 [patent_app_country] => US [patent_app_date] => 1998-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12323 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 686 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/034/06034067.pdf [firstpage_image] =>[orig_patent_app_number] => 125169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4260493 [patent_doc_number] => 06258776 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'Calcium-regulated kinase' [patent_app_type] => 1 [patent_app_number] => 9/133062 [patent_app_country] => US [patent_app_date] => 1998-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17139 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258776.pdf [firstpage_image] =>[orig_patent_app_number] => 133062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4293993 [patent_doc_number] => 06180597 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-30 [patent_title] => 'Upregulation of Type III endothelial cell nitric oxide synthase by rho GTPase function inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/132849 [patent_app_country] => US [patent_app_date] => 1998-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 27 [patent_no_of_words] => 21079 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/180/06180597.pdf [firstpage_image] =>[orig_patent_app_number] => 132849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3979519 [patent_doc_number] => 05948752 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-07 [patent_title] => 'Suppressory agents against hypercoagulation' [patent_app_type] => 1 [patent_app_number] => 9/132534 [patent_app_country] => US [patent_app_date] => 1998-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3671 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/948/05948752.pdf [firstpage_image] =>[orig_patent_app_number] => 132534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4194559 [patent_doc_number] => 06043341 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-28 [patent_title] => 'Cyclic peptide antifungal agents' [patent_app_type] => 1 [patent_app_number] => 9/129062 [patent_app_country] => US [patent_app_date] => 1998-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19226 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/043/06043341.pdf [firstpage_image] =>[orig_patent_app_number] => 129062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4059819 [patent_doc_number] => 06007833 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => 'Crosslinkable macromers bearing initiator groups' [patent_app_type] => 1 [patent_app_number] => 9/121248 [patent_app_country] => US [patent_app_date] => 1998-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10315 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/007/06007833.pdf [firstpage_image] =>[orig_patent_app_number] => 121248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4149430 [patent_doc_number] => 06103257 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'System for delivering pharmaceuticals to the buccal mucosa' [patent_app_type] => 1 [patent_app_number] => 9/118485 [patent_app_country] => US [patent_app_date] => 1998-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3633 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103257.pdf [firstpage_image] =>[orig_patent_app_number] => 118485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6623485 [patent_doc_number] => 20020016290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-07 [patent_title] => 'CYCLOSPORIN A FORMULATIONS AS NANOPARTICLES' [patent_app_type] => new [patent_app_number] => 09/113532 [patent_app_country] => US [patent_app_date] => 1998-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1919 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20020016290.pdf [firstpage_image] =>[orig_patent_app_number] => 09113532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4009518 [patent_doc_number] => 05962416 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Accelerating animal hoof growth with somatotropin' [patent_app_type] => 1 [patent_app_number] => 9/105651 [patent_app_country] => US [patent_app_date] => 1998-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3829 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962416.pdf [firstpage_image] =>[orig_patent_app_number] => 105651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4151689 [patent_doc_number] => 06107051 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Globulin protein 11S, usable as a seed impregnation marker during germination' [patent_app_type] => 1 [patent_app_number] => 8/983198 [patent_app_country] => US [patent_app_date] => 1998-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 19 [patent_no_of_words] => 9571 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/107/06107051.pdf [firstpage_image] =>[orig_patent_app_number] => 983198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4131586 [patent_doc_number] => 06034054 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Stable insulin formulations' [patent_app_type] => 1 [patent_app_number] => 9/096247 [patent_app_country] => US [patent_app_date] => 1998-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6937 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/034/06034054.pdf [firstpage_image] =>[orig_patent_app_number] => 096247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6514361 [patent_doc_number] => 20020026034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-28 [patent_title] => '3-AMINOETHYL-N-AMIDINO-2,5-DIHYDROPYRROLE DERIVATIVES HAVING ARGININE MIMETIC PROPERTIES' [patent_app_type] => new [patent_app_number] => 09/077879 [patent_app_country] => US [patent_app_date] => 1998-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14681 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20020026034.pdf [firstpage_image] =>[orig_patent_app_number] => 09077879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3912695 [patent_doc_number] => 06001814 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Serine protease inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/090274 [patent_app_country] => US [patent_app_date] => 1998-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8922 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001814.pdf [firstpage_image] =>[orig_patent_app_number] => 090274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4051781 [patent_doc_number] => 05932548 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Lysine containing peptides for treatment of heart disease' [patent_app_type] => 1 [patent_app_number] => 9/089955 [patent_app_country] => US [patent_app_date] => 1998-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3243 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932548.pdf [firstpage_image] =>[orig_patent_app_number] => 089955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4103133 [patent_doc_number] => 06100238 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Indole and tetrahydroisoquinoline containing Alpha-keto oxadiazoles as serine protease inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/089587 [patent_app_country] => US [patent_app_date] => 1998-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6587 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100238.pdf [firstpage_image] =>[orig_patent_app_number] => 089587 [rel_patent_id] =>[rel_patent_doc_number] =>)